These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Impact of prophylactic administration of Levosimendan on short-term and long-term outcome in high-risk patients with severely reduced left-ventricular ejection fraction undergoing cardiac surgery - a retrospective analysis. Grieshaber P; Lipp S; Arnold A; Görlach G; Wollbrück M; Roth P; Niemann B; Wilhelm J; Böning A J Cardiothorac Surg; 2016 Dec; 11(1):162. PubMed ID: 27906091 [TBL] [Abstract][Full Text] [Related]
25. Prophylactic treatment with levosimendan: a retrospective matched-control study of patients with reduced left ventricular function. Kolseth SM; Nordhaug DO; Stenseth R; Sellevold O; Kirkeby-Garstad I; Wahba A Eur J Cardiothorac Surg; 2009 Dec; 36(6):1024-30. PubMed ID: 19592266 [TBL] [Abstract][Full Text] [Related]
27. Levosimendan: a retrospective single-center case series. Berry WT; Hewson RW; Langrish CJ; McKenzie CA; Barrett NA J Crit Care; 2013 Dec; 28(6):1075-8. PubMed ID: 23998721 [TBL] [Abstract][Full Text] [Related]
28. Perioperative use of levosimendan: best practice in operative settings. Toller W; Algotsson L; Guarracino F; Hörmann C; Knotzer J; Lehmann A; Rajek A; Salmenperä M; Schirmer U; Tritapepe L; Weis F; Landoni G J Cardiothorac Vasc Anesth; 2013 Apr; 27(2):361-6. PubMed ID: 22658687 [No Abstract] [Full Text] [Related]
29. Levosimendan versus milrinone in neonates and infants after corrective open-heart surgery: a pilot study. Lechner E; Hofer A; Leitner-Peneder G; Freynschlag R; Mair R; Weinzettel R; Rehak P; Gombotz H Pediatr Crit Care Med; 2012 Sep; 13(5):542-8. PubMed ID: 22622649 [TBL] [Abstract][Full Text] [Related]
30. Levosimendan: a review of its use in the management of acute decompensated heart failure. Innes CA; Wagstaff AJ Drugs; 2003; 63(23):2651-71. PubMed ID: 14636085 [TBL] [Abstract][Full Text] [Related]
31. [Possibilities of using levosimendan in patients with idiopathic pulmonary hypertension]. Martyniuk TV; Arkhipova OA; Kobal' EA; Danilov NM; Chazova IE Ter Arkh; 2012; 84(9):83-8. PubMed ID: 23091860 [TBL] [Abstract][Full Text] [Related]
33. [LEVOSIMENDAN--THE FIRST 10 YEARS IN CLINICAL PRACTICE]. Rybka MM; Lobacheva GV Anesteziol Reanimatol; 2015; 60(5):80-4. PubMed ID: 26852586 [TBL] [Abstract][Full Text] [Related]
34. [Levosimendan and dobutamine have a similar profile for potential risk for cardiac arrhythmias during 24-hour infusion in patients with acute decompensated heart failure]. Tek M; Cavuşoğlu Y; Demirüstü C; Birdane A; Ünalır A; Görenek B; Göktekin Ö; Ata N Turk Kardiyol Dern Ars; 2010 Jul; 38(5):334-40. PubMed ID: 21200103 [TBL] [Abstract][Full Text] [Related]
36. [Role of Levosimendan in intensive care treatment of myocardial insufficiency]. Rehberg S; Ertmer C; Van Aken H; Lange M; Bröking K; Morelli A; Westphal M Anaesthesist; 2007 Jan; 56(1):30-43. PubMed ID: 17131137 [TBL] [Abstract][Full Text] [Related]
37. Cardiovascular effects of levosimendan in the early stages of endotoxemia. Cunha-Goncalves D; Perez-de-Sa V; Dahm P; Grins E; Thörne J; Blomquist S Shock; 2007 Jul; 28(1):71-7. PubMed ID: 17510599 [TBL] [Abstract][Full Text] [Related]
38. Levosimendan: a new option in acute cardiac failure. Holley AD; Ziegenfuss M Emerg Med Australas; 2006; 18(5-6):505-9. PubMed ID: 17083641 [No Abstract] [Full Text] [Related]
39. First Experience With Levosimendan Therapy After Correction of Congenital Heart Disease. Giordano R; Cantinotti M; Mannacio VA; Palma G J Cardiothorac Vasc Anesth; 2017 Feb; 31(1):e19-e21. PubMed ID: 28277244 [No Abstract] [Full Text] [Related]
40. Levosimendan compared with dobutamine in low output patients. Nieminen MS Minerva Anestesiol; 2003 Apr; 69(4):258-63. PubMed ID: 12766717 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]